← Open Payments lookup

JEFFREY KASSELMAN: Open Payments

NPI 1316005366 · RUSSELL, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$308 in 17 payments from 8 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $308

Food & beverage: $308
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.4$85
Novartis Pharmaceuticals Corporation3$63
AstraZeneca Pharmaceuticals LP3$45
ABBVIE INC.2$32
Electromed, Inc.2$27
Otsuka America Pharmaceutical, Inc.1$21
Insulet Corporation1$20
Lilly USA, LLC1$14

Products named: GEMTESA, LEQVIO, FARXIGA, SMARTVEST, REXULTI, Omnipod, UBRELVY, QULIPTA.

Industry payments across KS — which companies pay providers there.